Blog Posts

SECOND OPINION: PHARMA-BACKED REBATE RULE WOULD INCREASE OOP COSTS AND PREMIUMS FOR SENIORS — DO NOTHING TO LOWER RX PRICES

Oct 5, 2020

Big Pharma Claims Misguided Proposal Would Benefit Patients, Facts Show It Read More

DOSE OF REALITY: LAWMAKERS RIGHT TO TRAIN RENEWED FOCUS ON BIG PHARMA’S PRICE-GOUGING AND ANTI-COMPETITIVE TACTICS

Sep 29, 2020

Brand Name Drug Companies Must be Held Accountable for Pandemic Price Hikes Read More

DOSE OF REALITY: TRUMP ADMINISTRATION MUST DUMP REBATE RULE TO ACHIEVE SECOND TERM GOAL OF LOWERING PREMIUMS

Aug 26, 2020

Misguided Measure Would Increase Medicare Part D Premiums, Cost Taxpayers More Read More

DOSE OF REALITY: DEBUNKING BIG PHARMA’S SUPPLY CHAIN BLAME GAME

Aug 14, 2020

Drug Companies Target PBMs and Rebates That Play a Critical Role in Lowering Read More

BIG PHARMA EARNINGS WATCH: BRISTOL-MYERS SQUIBB

Aug 6, 2020

Brand Name Drug Company Completes Sweep of Big Pharma Giants Who Beat Wall Read More

DOSE OF REALITY: UNPACKING THE REBATE RULE’S BIG PHARMA ORIGINS

Aug 3, 2020

Little Surprise Big Pharma Bailout That Would Hike Medicare Premiums Was A Read More

BIG PHARMA EARNINGS WATCH: ABBVIE & MERCK

Jul 31, 2020

Brand Name Drug Companies Continue Streak of Beating Wall Street Expectations Read More

Big Pharma Earnings Watch: AstraZeneca & Eli Lilly

Jul 31, 2020

Brand Name Drug Companies See Soaring Profits After Hiking Prices Today Read More

BIG PHARMA EARNINGS WATCH: SANOFI

Jul 29, 2020

Big Pharma Giant Sees Profits Jump After July Price Hikes Big Pharma giant Read More

BIG PHARMA EARNINGS WATCH: PFIZER & AMGEN

Jul 29, 2020

Brand Name Big Pharma Giants Surpass Expectations After Hiking Prices New Read More

THEY SAID IT! COVERAGE HIGHLIGHTS REVIVED REBATE RULE AN UNWORKABLE BIG PHARMA BAILOUT

Jul 28, 2020

Reception of Misguided Reboot Focuses on Premium Increases, Cost to Taxpayers, Read More